DEERFIELD, Ill. / Aug 01, 2023 / Business Wire / Walgreens is offering flu and respiratory syncytial virus (RSV) vaccination appointments nationwide. Individuals ages 3 years and older can receive a flu shot, and eligible individuals ages 60 years and older can receive an RSV vaccine.* Patients can visit the pharmacy or schedule an appointment through the Walgreens app, by visiting Walgreens.com/ScheduleVaccine or by calling 1-800-WALGREENS.
Walgreens makes it easy to help get ahead of respiratory virus season with convenient and timely options for vaccination, testing and treatment all in one place.
“We know our trusted pharmacy teams will be relied upon this fall to prevent the spread of seasonal viruses, as patients see their pharmacist almost twice as often as they see their physician or other healthcare provider1,” said Rick Gates, Walgreens chief pharmacy officer. “All of us need to do our part to stay healthy and neighborhood pharmacies are the most accessible destinations for the quick, routine and preventative care that patients have come to expect post-pandemic.”
When community spread of flu, COVID-19 and RSV picks up this fall, Walgreens has additional services planned.
Later this year, the Walgreens Flu Index® will also launch for the 2023-2024 season. Respiratory illness activity will also be tracked via the Walgreens COVID-19 Index, one of the last remaining surveillance trackers in the U.S., to help communities monitor flu activity and COVID-19 positivity data.
About Walgreens
Walgreens (www.walgreens.com) is included in the U.S. Retail Pharmacy and U.S. Healthcare segments of Walgreens Boots Alliance, Inc. (Nasdaq: WBA), an integrated healthcare, pharmacy and retail leader with a 170-year heritage of caring for communities. WBA’s purpose is to create more joyful lives through better health. Operating nearly 9,000 retail locations across America, Puerto Rico and the U.S. Virgin Islands, Walgreens is proud to be a neighborhood health destination serving nearly 10 million customers each day. Walgreens pharmacists play a critical role in the U.S. healthcare system by providing a wide range of pharmacy and healthcare services, including those that drive equitable access to care for the nation’s underserved populations. To best meet the needs of customers and patients, Walgreens offers a true omnichannel experience, with fully integrated physical and digital platforms supported by the latest technology to deliver high-quality products and services in communities nationwide.
1Valliant SN, Burbage SC, Pathak S, Urick BY. Pharmacists as accessible health care providers: quantifying the opportunity. J Manag Care Spec Pharm. 2022 Jan;28(1):85-90. doi: 10.18553/jmcp.2022.28.1.85.
*RSV vaccines are available in most states and appointments will be added on a rolling basis over the next two weeks as store locations receive vaccines.
**Please note that walk-in appointments are based on availability.
***Offer valid 9/01/23 thru 12/31/23 in store only with coupon. Coupon offer not valid in AR, NJ, or NY. Limit 1 storewide coupon redeemed per transaction. Must be a myWalgreens® member. Walgreens Cash rewards are not legal tender. No cash back. Walgreens Cash rewards earned on this transaction good on future purchases and not eligible for redemption in the same transaction. Valid in store only with coupon. Purchase requirement must be met in a single transaction, before taxes and after discounts, store credit and redemption dollars have been applied. Void if copied or transferred. Other exclusions apply. Complete details at myWalgreens.com.
Last Trade: | US$8.21 |
Daily Change: | -0.08 -0.97 |
Daily Volume: | 24,873,335 |
Market Cap: | US$7.090B |
October 15, 2024 October 07, 2024 August 19, 2024 August 01, 2024 |
Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MOREImmix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB